A detailed history of Group One Trading, L.P. transactions in Essa Pharma Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 27,795 shares of EPIX stock, worth $47,529. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,795
Holding current value
$47,529
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.45 - $7.1 $123,687 - $197,344
27,795 New
27,795 $168,000
Q4 2023

Feb 14, 2024

SELL
$2.74 - $7.35 $84,076 - $225,534
-30,685 Reduced 73.3%
11,175 $73,000
Q3 2023

Nov 09, 2023

BUY
$2.65 - $3.31 $28,079 - $35,072
10,596 Added 33.89%
41,860 $129,000
Q2 2023

Aug 09, 2023

BUY
$2.6 - $3.34 $81,286 - $104,421
31,264 New
31,264 $84,000
Q4 2022

Feb 09, 2023

BUY
$1.5 - $4.82 $163 - $525
109 New
109 $0

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $75.4M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.